Your browser doesn't support javascript.
loading
Capturing the holistic value of biosimilars in Europe - part 1: a historical perspective.
Mestre-Ferrandiz, Jorge; Czech, Marcin; Smolen, Josef S; Cornes, Paul; Aapro, Matti S; Danese, Silvio; Deitch, Stephen; Tyldsley, Hannah; Foster, Will; Shah, Pooja; Latymer, Mark; Vulto, Arnold G.
Affiliation
  • Mestre-Ferrandiz J; Department of Economics, Universidad Carlos III, Madrid, Spain.
  • Czech M; Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland.
  • Smolen JS; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.
  • Cornes P; Comparative Outcomes Group, Bristol, UK.
  • Aapro MS; Cancer Center, Clinique de Genolier, Vaud, Switzerland.
  • Danese S; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy.
  • Deitch S; Life Science Practice, Charles River Associates, London, UK.
  • Tyldsley H; Life Science Practice, Charles River Associates, London, UK.
  • Foster W; Life Science Practice, Charles River Associates, London, UK.
  • Shah P; US Medical Affairs, Pfizer, Collegeville, PA, USA.
  • Latymer M; Global Medical Affairs, Biosimilars Portfolio, Pfizer, Sandwich, UK.
  • Vulto AG; Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands.
Expert Rev Pharmacoecon Outcomes Res ; 24(2): 237-250, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38175140

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals Type of study: Guideline / Qualitative_research Limits: Humans Country/Region as subject: Europa Language: En Journal: Expert Rev Pharmacoecon Outcomes Res Journal subject: FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: España Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals Type of study: Guideline / Qualitative_research Limits: Humans Country/Region as subject: Europa Language: En Journal: Expert Rev Pharmacoecon Outcomes Res Journal subject: FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: España Country of publication: Reino Unido